You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Open label

Showing 9976 - 10000 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Recurrent or Metastatic Squamous Cell Carcinoma of Head and Neck Trial in Shanghai (MRG003)

Recruiting
  • Recurrent or Metastatic Squamous Cell Carcinoma of Head and Neck
  • Shanghai, Shanghai, China
    Shanghai East Hospital
Apr 29, 2021

Castration-resistant Prostate Cancer, Metastasis Trial in France (Carboplatin)

Terminated
  • Castration-resistant Prostate Cancer
  • Metastasis
  • Caen, France
  • +3 more
Apr 28, 2021

Multiple Myeloma Trial in Torino (Pomalidomide, Cyclophosphamide, Dexamethasone)

Terminated
Has Results
  • Multiple Myeloma
  • Torino, Italy
    Fondazione EMN Italy Onlus
Feb 16, 2021

Seasonal Influenza Trial in Germany (Influenza Vaccine (Surface Antigen, Inactivated) Ph.Eur, Formulation 2010/2011)

Completed
  • Seasonal Influenza
  • Influenza Vaccine (Surface Antigen, Inactivated) Ph.Eur, Formulation 2010/2011
  • Germany, Germany
    Novartis Investigational Site
Mar 9, 2021

Fat-free Masss, Muscle Strength, Neuromuscular Function Trial in Glassboro (Fish oil, Coconut oil)

Suspended
  • Fat-free Masss
  • +2 more
  • Fish oil
  • Coconut oil
  • Glassboro, New Jersey
    Rowan University
Mar 8, 2021

Osteogenesis Imperfecta Trial in Vellore (BOOST cells)

Unknown status
  • Osteogenesis Imperfecta
  • BOOST cells
  • Vellore, Tamil Nadu, India
    Christian Medical College
Nov 6, 2020

Lung Cancer Stage IV Trial (Osimertinib Oral Tablet)

Not yet recruiting
  • Lung Cancer Stage IV
  • Osimertinib Oral Tablet
  • (no location specified)
Aug 17, 2020

Follicular Lymphoma Trial in Worldwide (Mosunetuzumab (IV), Tocilizumab, Lenalidomide)

Recruiting
  • Follicular Lymphoma
  • Mosunetuzumab (IV)
  • +3 more
  • Duarte, California
  • +21 more
Jan 10, 2023

Mucopolysaccharidosis Type IIIA Trial in Worldwide (LYS-SAF302)

Active, not recruiting
  • Mucopolysaccharidosis Type IIIA
  • Orange, California
  • +7 more
Aug 30, 2021

NSCLC, NSCLC, Carcinoma, Bronchogenic Trial in United States (furmonertinib 240 mg, furmonertinib 160 mg, platinum-based chemo)

Recruiting
  • Non-Small Cell Lung Cancer
  • +13 more
  • furmonertinib 240 mg
  • +2 more
  • Yuma, Arizona
  • +37 more
Dec 14, 2022

Hemophilia A Trial in Worldwide (SPK-8011)

Recruiting
  • Hemophilia A
  • SPK-8011
  • Sacramento, California
  • +18 more
Jul 15, 2022

Tularemia Trial in Fort Deterick (Live Attenuated Tularemia Vaccine)

Not yet recruiting
  • Tularemia
  • Live Attenuated Tularemia Vaccine
  • Fort Deterick, Maryland
    Special Immunizations Program, Division of Medicine, USAMRIID
Feb 10, 2021

NSCLC Metastatic, First-line Treatment Trial in Tianjin (CIK cell injection, Sintilimab Injection, Pemetrexed)

Not yet recruiting
  • Non-small Cell Lung Cancer Metastatic
  • First-line Treatment
  • CIK cell injection
  • +4 more
  • Tianjin, Tianjin, China
    Tianjin Medical University Cancer Institute and Hospital
Apr 6, 2021

Healthy Trial in Middlesex (Lu AF88434, [11C]-Lu AF88434)

Completed
  • Healthy
  • Lu AF88434
  • [11C]-Lu AF88434
  • Middlesex, United Kingdom
    Parexel International Northwick Park Hospital (Level 7)
Feb 23, 2021

Atopic Dermatitis Trial in Boston (Crisaborole 2% Top Oint)

Unknown status
  • Atopic Dermatitis
  • Crisaborole 2% Top Oint
  • Boston, Massachusetts
    MGH Clinical Unit for Research Trials in Skin (CURTIS)
Feb 22, 2021

NSCLC, Stage I Trial in Finland, Norway, Sweden (Durvalumab)

Recruiting
  • NSCLC, Stage I
  • Helsinki, Finland
  • +14 more
Mar 3, 2021

ß-Thalassemia Major Trial in Shenzhen (ß-globin restored autologous HSC)

Not yet recruiting
  • β-Thalassemia Major
  • β-globin restored autologous HSC
  • Shenzhen, Guangdong, China
    Beijing Genomics Institute At Shenzhen
Oct 13, 2020

Multiple Myeloma, Refractory Trial in Greece, Israel (Selinexor, Dexamethasone, Bortezomib)

Recruiting
  • Multiple Myeloma, Refractory
  • Patra, Achaia, Greece
  • +15 more
Apr 4, 2022

COPD, Smoking Cessation, Lung Diseases, Obstructive Trial in Copenhagen, Hellerup (High-intensity smoking cessation

Not yet recruiting
  • Chronic Obstructive Pulmonary Disease
  • +3 more
  • High-intensity smoking cessation intervention
  • Low-intensity smoking cessation intervention
  • Copenhagen, Denmark
  • +3 more
Aug 4, 2021

Hemophilia A Trial in China (Recombinant Human Coagulation Factor VIII-Fc Fusion Protein for Injection)

Active, not recruiting
  • Hemophilia A
  • Recombinant Human Coagulation Factor VIII-Fc Fusion Protein for Injection
  • Hefei, Anhui, China
  • +16 more
Apr 13, 2021

Non Toxic Multinodular Goiter, High Intensity Focused Ultrasound, RAI Trial in Hong Kong (Echopulse, Radioactive iodine

Not yet recruiting
  • Non Toxic Multinodular Goiter
  • +2 more
  • Echopulse
  • Radioactive iodine (Radioidine i131)
  • Hong Kong, Hong Kong
    Queen Mary Hospital
Apr 27, 2021

Healthy Trial in Singapore (Epanutin Infatabs (Phenytoin), Dilantin Infatabs (Phenytoin))

Completed
Has Results
  • Healthy
  • Epanutin Infatabs (Phenytoin)
  • Dilantin Infatabs (Phenytoin)
  • Singapore, Singapore
    Pfizer Investigational Site
Jan 26, 2021

Relapsed/Refractory Peripheral T-cell Lymphoma, Relapsed/Refractory Classical Hodgkins Lymphoma Trial in Worldwide (AZD4573)

Recruiting
  • Relapsed/Refractory Peripheral T-cell Lymphoma
  • Relapsed/Refractory Classical Hodgkins Lymphoma
  • Duarte, California
  • +33 more
Jan 5, 2023

Urothelial Carcinoma Trial in United States (disitamab vedotin, pembrolizumab)

Recruiting
  • Urothelial Carcinoma
  • Los Angeles, California
  • +17 more
Jan 3, 2023

Recurrent DLBCL, Recurrent DLBCL, Not Otherwise Specified, Recurrent Grade 3b Follicular Lymphoma Trial in Seattle

Recruiting
  • Recurrent Diffuse Large B-Cell Lymphoma
  • +8 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Dec 30, 2022